ZLZhen Li

Zhen Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Zhen Li has a total of 81 co-authors. Here are the top co-authors by number of shared publications:

  • Zhaohui Hua

    Department of vascular surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

    11 shared publications
  • Hui Cao

    Department of Endovascular Surgery, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

    10 shared publications
  • Peng Xu

    Department of Endovascular Surgery, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

    10 shared publications
  • Shirui Liu

    Department of Endovascular Surgery, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

    9 shared publications
  • Zhouyang Jiao

    Department of Endovascular Surgery, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

    9 shared publications
  • Chong Li

    Vascular Care Group, Darien, CT

    6 shared publications

Latest Publications

  • Open Access

    Efficacy of left subclavian artery laser in situ fenestration combined with hybrid arch debranching surgery for aortic arch reconstruction in patients with Stanford type A aortic dissection

    by Qi Zhang, Hao Zhao, Yongqiang Yue, Shuai Zhang, Likun Sun, Peng Xu, Chao Liu, Zhaohui Hua, Zhen Li

    Objective: To investigate the early and mid-term outcomes of in situ laser fenestration (ISLF) of the left subclavian artery (LSA) combined with hybrid aortic arch debranching for aortic arch reconstruction in Stanford type A aortic dissection. Methods: This retrospective study analyzed 57 patients (60+ years) treated from 2018 to 2023. LSA reconstruction-related complications were defined as: anastomotic bleeding, LSA occlusion, stent migration, or fenestration-related endoleak. Patients were divided into ISLF + debranching ( n = 29) and debranching-only ( n = 28) groups. Outcomes were compared using t-tests and Kaplan–Meier analysis. Results: The ISLF group had shorter operative time (323.1 ± 10.3 vs. 329.4 ± 7.2 min, P = 0.009) and higher LSA reconstruction success (100% vs. 75%, P = 0.013). LSA complication rates were lower in the ISLF group (3.4% vs. 28.6%, P = 0.025). Five-year survival was similar (79.3% vs. 75.0%, P = 0.575). Conclusion: ISLF with hybrid debranching improves LSA reconstruction success and reduces complications without affecting survival.


  • Risk factors for restenosis following carotid endarterectomy in patients with full collapse carotid near occlusion

    by Linfeng Zhang, Yiming Chai, Zhouyang Jiao, Peng Xu, Hui Cao, Shirui Liu, Zhiling Ma, Zhaohui Hua, Zhen Li


  • In Situ Laser Fenestration for Revascularization of the Left Subclavian Artery in Diseases of the Aortic Arch

    by Xu Li, Zhen Li, Zhouyang Jiao, Hui Cao, Peng Xu, Baoning Zhou, Hao Zhao, Zhaohui Hua

    Thoracic endovascular aortic repair (TEVAR) has become a widely established treatment for aortic arch pathologies in recent years. However, lesions near or involving the origin of the left subclavian artery (LSA) often present challenges in securing an adequate proximal landing zone. Various technical approaches, including parallel graft techniques, fenestration, chimney grafts, branched devices, and others, have been developed to optimize the proximal landing zone while preserving LSA perfusion. Among these approaches, in situ laser fenestration (ISLF) of the LSA has emerged as a highly versatile and safe technique, demonstrating high success rates. This article provides a comprehensive overview of perioperative management and critical procedural steps for performing ISLF of the LSA, and presents clinical outcomes from a consecutive case series with a technical success rate of 94.5%. The objective is to offer vascular surgeons and interventional radiologists detailed insights to support the safe and effective application of this advanced technique.


  • JoVE Video Dataset

    by Xu Li, Zhen Li, Zhouyang Jiao, Hui Cao, Peng Xu, Baoning Zhou, Hao Zhao, Zhaohui Hua

    Thoracic endovascular aortic repair (TEVAR) has become a widely established treatment for aortic arch pathologies in recent years. However, lesions near or involving the origin of the left subclavian artery (LSA) often present challenges in securing an adequate proximal landing zone. Various technical approaches, including parallel graft techniques, fenestration, chimney grafts, branched devices, and others, have been developed to optimize the proximal landing zone while preserving LSA perfusion. Among these approaches, in situ laser fenestration (ISLF) of the LSA has emerged as a highly versatile and safe technique, demonstrating high success rates. This article provides a comprehensive overview of perioperative management and critical procedural steps for performing ISLF of the LSA, and presents clinical outcomes from a consecutive case series with a technical success rate of 94.5%. The objective is to offer vascular surgeons and interventional radiologists detailed insights to support the safe and effective application of this advanced technique.

  • Open Access

    An Injectable Ibuprofen Sustained-Release Composite Hydrogel System Effectively Accelerates Diabetic Wound Healing via Anti-Inflammatory Effects and Angiogenesis

    by Zhibin Li, Haijiang Dong, Shenyu Yang, Ximei Wang, Zhen Li

    Purpose: Excessive inflammation in diabetic wounds, driven by hyperglycemia, prolongs healing, increases the risk of non-healing ulcers, and can lead to severe complications such as amputation or life-threatening infections. Recurrent wound infections and prolonged treatment impose significant economic and psychological burdens, drastically reducing patients’ quality of life. Modulating the inflammatory response is a promising strategy to accelerate diabetic wound healing. Ibuprofen (IBU), a widely used anti-inflammatory and analgesic agent, has the potential to promote healing by mitigating excessive inflammation and alleviating wound-associated pain. However, its clinical application is hindered by poor water solubility and a short half-life. Therefore, a controlled and sustained-release system for IBU could enhance its therapeutic efficacy in diabetic wound management. Materials and Methods: Here, we present an in situ multi-crosslinked composite hydrogel system that integrates oxidized alginate (OSA), methacryloylated gelatin (GelMA), and an ibuprofen/amino-modified β-cyclodextrin inclusion complex (IBU/CD-NH2) via ion crosslinking, photocrosslinking, and Schiff-base reactions. Results: The optimized hydrogel formulation was synthesized at 35°C, with a P/A molar ratio of 2 and an methacrylamide(MA) volume fraction of 20%. Physicochemical and biocompatibility analyses demonstrated that the IBU-loaded composite hydrogel exhibits enhanced mechanical strength, favorable biocompatibility, tunable degradation, and injectability. This system effectively addresses IBU’s solubility and absorption challenges while conforming to wounds of varying shapes and sizes, enabling controlled and sustained drug release. Cellular and animal studies confirmed that the hydrogel continuously and uniformly releases IBU, exerting anti-inflammatory effects while promoting angiogenesis and fibroblast migration. This leads to enhanced granulation tissue formation, collagen deposition, and epidermal regeneration, significantly accelerating wound closure within 14 days. Conclusion: By simultaneously suppressing inflammation and stimulating tissue regeneration through controlled IBU release, this hydrogel system offers a highly effective strategy for diabetic wound healing and holds strong potential for clinical application.


  • Open Access

    A prospective multicenter, randomized controlled, non-inferiority trial of bovine pericardial versus polyurethane patching in carotid endarterectomy

    by Yanfei Chen, Yao Feng, Xiao Tang, Yabo Huang, Peng Zhou, Liyong Zhang, Jiheng Hao, Zhen Li, Zhaohui Hua, Daqiao Gao, et al.

    Carotid endarterectomy (CEA) is the first-line treatment for internal carotid artery stenosis that can lead to stroke. This study aimed to compare the incidence of early adverse clinical events and restenosis between patient groups receiving the newly developed bovine pericardial (BP) and polyurethane patches during CEA. We conducted a multicenter, randomized, non-inferiority trial at five tertiary centers in China. Participants were assigned to either the BP patch or polyurethane patch group. The primary outcome was freedom from restenosis at 1 year after surgery. Restenosis was defined as a narrowing of >50% in the target artery on duplex ultrasound or computed tomography angiography examination. The total number of participants was 120, including 60 each randomized to the BP patch and polyurethane patch groups. Demographics were similar in both groups. Death or significant disability was comparable between the two groups (3:1, p = 0.619) during the perioperative period. At the 12-month assessment (n = 112), three patients had severe restenosis: two in the BP patch group (n = 57) and one in the polyurethane patch group (n = 55). There was no significant statistical difference in restenosis, morbidity, or mortality between the two groups (p > 0.4), indicating that the BP patch was non-inferior to the polyurethane patch (p = 0.013 for the full analysis set; p = 0.016 for the per-protocol set). The two groups of patches had similar safety and effectiveness, and the BP patch was non-inferior to the mature polyurethane patch available on the market.

  • Open Access

    Evaluating the effectiveness of immediate vs. elective thoracic endovascular aortic repair for blunt thoracic aortic injury

    by Zhaohui Hua, Baoning Zhou, Wenhao Xue, Zhibin Zhou, Jintao Shan, Lei Xia, Yunpeng Luo, Yiming Chai, Zhen Li


  • Open Access

    Classification and management strategy of spontaneous carotid artery dissection

    by Baoning Zhou, Zhaohui Hua, Chong Li, Zhouyang Jiao, Hui Cao, Peng Xu, Shirui Liu, Zhen Li


  • Open Access

    One-year results of the Flowdynamics Dense Mesh Stent for residual dissection after proximal repair of stanford type A or type B aortic dissection: a multicenter, prospective, and randomized study

    by Chen Lu, Weixun Duan, Zhen Li, Chenhao Wang, Peng Yang, Yu Liu, Jian Zuo, Jia M.D Hu

    Objective: Negative remodeling of the distal aorta following proximal repair for acute aortic dissection has garnered growing attention. This clinical scenario has spurred the development of techniques and devices. A multicenter, prospective, and randomized controlled study was conducted with the aim of confirming the safety and effectiveness of a newly-designed flowdynamics dense mesh stent for the treatment of residual dissection after proximal repair. Methods: Patients with nonchronic residual dissection affecting visceral branches were prospectively enrolled at three centers and randomly allocated to either the FDMS group or the control group. Primary endpoints encompassed all-cause and aortic-related mortality, while the patency of branch arteries is indeed a key focal metric. Morphological changes (diameter, area, and volume) were analyzed to demonstrate the therapeutic effect. Results: One hundred twelve patients were recruited in the clinical trial, and 103 patients completed the 12-month follow-up. The rate of freedom from all-cause and aortic-related death in the FDMS group was 94.64 and 100%, respectively. All visceral branches remained patent. The FDMS group exhibited a substantial expansion in TL and a notable shrinkage in FL at the planes below renal arteries (ΔArea TL: FDMS vs. Control, 0.74±0.46 vs. 0.34±0.66 cm2, PFL: FDMS vs. Control, −0.72±1.26 vs. −0.12±0.86 cm, P=0.01) and 5 cm below renal arteries (ΔArea TL: FDMS vs. Control, 1.06±0.75 vs. 0.16±0.63 cm2, PFL: FDMS vs. Control, −0.53±1.43 vs. −0.25±1.00 cm, P=0.27). Meanwhile, the FDMS group demonstrated an increase of 22.55±11.14 cm3 in TL (P3 in FL (P=0.08). Conclusions: This newly-designed FDMS for endovascular repair of residual dissection following the proximal repair is demonstrated to be safe and effective at 12 months.


  • Open Access

    Classification and management strategy of spontaneous carotid artery dissection

    by Baoning Zhou, Chong Li, Zhouyang Jiao, Hui Cao, Peng Xue, Shirui Liu, Zhen Li, Zhaohui Hua

    Background and Purpose: Spontaneous carotid artery dissections (sCAD) are the main cause of stroke in middle-aged and young people. There is still a lack of clinical classification to guide the management of sCAD. We reviewed our experience with 179 sCAD patients and proposed a new classification for sCAD with prognostic and therapeutic significance. Methods: This is a retrospective review of prospectively collected data from June 2018 to June 2023 of sCAD patients treated at a large tertiary academic institution in an urban city in China. Depending on the degree of luminal narrowing and pseudoaneurysm formation on imaging, sCAD was classified into four types. Type IV dissections were divided into type IVA and type IVB dissections according to the presence of intracranial occlusion. Results: A total of 179 patients and 197 dissected arteries met the inclusion criteria. More than two-thirds of type I dissections are completely recanalized after antithrombotic therapy, and only one case (1.8%) had recurrent ischemic stroke. A total of 38 % of type II dissections and 73% of type III dissections received endovascular treatment (EVT) for persistent flow-limited dissections, enlargement of pseudoaneurysm, or aggravation of clinical symptoms despite antithrombotic therapy. Type IV dissections are more likely to lead to the occurrence of ischemic stroke, and presented with more severe symptoms. About 33% of type IVB dissections received emergent intervention due to intracranial occlusion or aggravation of symptoms after medical treatment. Conclusions: This study proposes a novel and more comprehensive classification method and management strategy for sCAD. Antithrombotic therapy is beneficial to reduce the risk of recurrent stroke for stable sCAD like type I. Non-emergent EVT can be an alternative therapeutic approach for patients who meet indications as in type II to IVA. Urgent procedure with neurovascular intervention might be needed in those with type IVB SCAD. The short-term results of EVT for sCAD are encouraging, and long-term device-related and functional outcome should be elucidated.